Article ID Journal Published Year Pages File Type
5702115 Journal of Thoracic Oncology 2016 28 Pages PDF
Abstract
These results demonstrate the implication of CCL2 in MPM pathogenesis and designate M-CSF as a new potential biomarker of MPM. This study also identifies CCL2 and colony-stimulating factor 1 receptor/M-CSF as interesting new targets to modulate pro-tumorigenic properties of the tumor microenvironment.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , ,